Myeloma as a Second Malignancy following AML: Is a Second Allo Equivalent to Auto?

Figure 1

Chimerism analysis showing complete donor type in T-and non-T-cell lineages in the bone marrow (a, b) and mixed chimerism in the plasmacytoma (c).

(a)

(b)

(c)